Malignant brain tumor
Conditions
Interventions
Intervention type:DRUG
Name of intervention:ME2906
Dose form / Japanese Medical Device Nomenclature:INJECTION,OTHER
Route of administration / Site of application:INTRAVENOUS BOLUS,NOT APPLICABLE
Dose
Sponsors
Faculty of Advanced Techno-Surgery,Institute of Advanced Biomedical Engineering and Science,Tokyo Women's Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Preoperative diagnostic imaging reveals the possibility of a primary malignant brain tumor 2)Patients suitable for tumor resection 3)Pretreatment MRI revealing that 50% or more of tumor mass is in supratentorial region 4)Pretreatment MRI revealing no tumor on optic nerve, olfactory nerve or pituitary gland 5)Pretreatment MRI revealing no dissemination 6)Patients themselves providing written consent to participation in the study etc.
Exclusion criteria
Exclusion criteria: 1)Severe cardiovascular, blood, hepatic, gastrointestinal, renal, respiratory, endocrine, neurologic or psychiatric disorder 2)Serious bleeding or shock 3)Prone to bleeding 4)Serious infection 5)Pregnant or possibly pregnant women, or lactating women 6)Other patients judged by investigator or sub-investigator as inappropriate for the study etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival, Response rate, etc. | — |
Countries
Japan
Contacts
Public ContactHiroshi Iseki
Institute of Advanced Biomedical Engineering and Science,Tokyo Women's Medical University
Outcome results
None listed